Zhibin Qiao (乔志斌) received his master's degree in Biology at School of Life Sciences and Technology, Tongji University. He worked at Shanghai East Hospital from August 2020 to December 2021. He joined Chen lab in January 2022. He is interested in using multiple approach including CRISPR/Cas9 gene editing and Epigenetic analysis to elucidate the role of transcription regulation during differentiation in human stem cell models.